Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann Rheum Dis. 2014 Aug;73(8):1591-3. doi: 10.1136/annrheumdis-2014-205278. Epub 2014 Apr 16.

Basiliximab may improve the survival rate of rapidly progressive interstitial pneumonia in patients with clinically amyopathic dermatomyositis with anti-MDA5 antibody.

Author information

  • 1Department of Pneumology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • 2Department of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

KEYWORDS:

Autoimmune Diseases; Dermatomyositis; T Cells

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk